Matthew Falagas MD, MSc, DSc

 

 
REVIEWER IN THE EVALUATION OF GRANT APPLICATIONS
 
  1. National Medical Research Council, Singapore; grant proposals (2006, 2008, 2010, 2013, 2014)
  2. Innovative Medicines Initiative (IMI), European Union, Brussels (2010)
  3. Ministry of Science and Technology, Portugal; grant applications (2009)
  4. European Society of Intensive Care Medicien (ESICM); grant applications (2008)
  5. Gent University, Gent, Belgium; research professorships (2008)
  6. Research Fund for the Control of Infectious Disease and the Health and Health Services Research Fund, Food and Health Bureau, Hong Kong; grant proposals (2008, 2009)
  7. Medical Research Council, UK; grant proposals (2007)
  8. Medical Research Council, Cape Town, South Africa; grant proposals (2007)
  9. British Society for Antimicrobial Chemotherapy; systematic review grant applications (2006)
  10. Athens Medical Society, Greece; “P. Papastamatis” award (2002)
 
REVIEWER IN THE EVALUATION OF CONFERENCE ABSTRACTS
 
  1. 23rd European Conference of Clinical Microbiology and Infection Diseases (ECCMID), 2013
  2. 22th European Conference of Clinical Microbiology and Infection Diseases (ECCMID), 2012
  3. 21st European Conference of Clinical Microbiology and Infection Diseases (ECCMID), 2011
  4. 20th European Conference of Clinical Microbiology and Infection Diseases (ECCMID), 2010
  5. 19th European Conference of Clinical Microbiology and Infection Diseases (ECCMID), 2009
  6. 18th European Conference of Clinical Microbiology and Infection Diseases (ECCMID), 2008
  7. 25th International Congress of Chemotherpy (ICC)/17th European Conference of Clinical Microbiology and Infection Diseases (ECCMID), 2007
  8. 16th European Conference of Clinical Microbiology and Infection Diseases (ECCMID), 2006
  9. 15th European Conference of Clinical Microbiology and Infection Diseases (ECCMID), 2005
  10. 14th European Conference of Clinical Microbiology and Infection Diseases (ECCMID), 2004
 

EDITORIAL/ADVISORY BOARD

 
  1. Drug Resistance Updates
  2. PLoS ONE
  3. European Journal of Clinical Microbiology and Infectious Diseases
  4. Journal of Infection and Public Health
  5. Virulence
  6. Therapy
  7. Medscape Infectious Diseases
 

GUEST EDITOR

 
  1. Infectious Diseases Clinics of North America; “Meta-analysis in infectious diseases” (06/2009)
  2.   Clinical Orthopedics and Related Research (CORR); symposium on “Spinal infections” (03/2006)
 

           

 

CITATIONS

 

My papers have been cited:

 
  1. About 25000 times in papers published in journals indexed by Google Scholar.
  2. About 10000 times in papers published in journals indexed by Thomson Scientific (Web of Science, Institute of Scientific Information - ISI), Philadelphia, Pennsylvania.
  3. H-index: 79
  4. I-10-index: 406
 
PUBLICATIONS: ORIGINAL RESEARCH PAPERS (PEER-REVIEWED)
 
  1. Infect Dis Theocharis G, Rafailidis PI, Rodis D, Kontopidis I, Barbas SG, Falagas ME. Outpatient parenteral antibiotic therapy (OPAT) at home in Attica, Greece. Eur J Clin Microbiol (in press).
  2. Mavros MN, Bardakas V, Rafailidis PI, Sardi TA, Demetriou E, Falagas ME. Comparison of number of citations to full original articles versus brief reports. Scientometrics (in press).
  3. Samonis G, Korbila IP, Maraki S, Michailidou I, Vardakas KZ, Kofteridis D, Dimopoulou D, Gkogkozotou VK, Falagas ME.Trends of isolation of intrinsically resistant to colistin Enterobacteriaceae and association with colistin use in a tertiary hospital.Eur J Clin Microbiol Infect Dis. 2014 Apr 15. [Epub ahead of print]
  4. Plessa E, Tansarli GS, Xanthopoulos D, Falagas ME. Morbidity and outcomes of foreign travelers in zakynthos island, Greece: a retrospective study.PLoS ONE. 2014;9:e94416.
  5. Fysaraki M, Samonis G, Valachis A, Daphnis E, Karageorgopoulos DE, Falagas ME, Stylianou K, Kofteridis DP.Incidence, clinical, microbiological features and outcome of bloodstream infections in patients undergoing hemodialysis. Int J Med Sci. 2013;10:1632-8.
  6. Falagas ME, Korbila IP, Kapaskelis A, Manousou K, Leontiou L, Tansarli GS.Trends of mortality due to septicemia in Greece: an 8-year analysis.PLoS ONE. 2013;8:e67621.
  7. Karageorgopoulos DE, Maraki S, Vatopoulos AC, Samonis G, Schito GC, Falagas ME.Antimicrobial activity of prulifloxacin in comparison with other fluoroquinolones against community-acquired urinary and respiratory pathogens isolated in Greece.Eur J Clin Microbiol Infect Dis. 2013;32:1417-22.
  8. Samonis G, Vardakas KZ, Maraki S, Tansarli GS, Dimopoulou D, Kofteridis DP, Andrianaki AM, Falagas ME. A prospective study of characteristics and outcomes of bacteremia in patients with solid organ or hematologic malignancies. Support Care Cancer 2013;21:2521-6.
  9. Mavros MN, Alexiou VG, Vardakas KZ, Falagas ME. Understanding of statistical terms routinely used in meta-analyses: an international survey among researchers. PLoS ONE 2013;8:e47229.
  10. Falagas ME, Zarkali A, Karageorgopoulos DE, Bardakas V, Mavros MN. The impact of article length on the number of future citations: a bibliometric analysis of general medicine journals.PLoS One 2013;8:e49476
  11. Samonis G, Maraki S, Vouloumanou EK, Georgantzi GG, Kofteridis DP, Falagas ME. Antimicrobial susceptibility of non-fermenting Gram-negative isolates to isepamicin in a region with high antibiotic resistance. Eur J Clin Microbiol Infect Dis 2012;31:3191-8
  12. Falagas ME, Bardakas V, Mavros MN. Biomedical research productivity in Greece:
 

     effect of the financial crisis. Int J Epidemiol 2012;41:1206-7.

 
  1. Theocharis G, Tansarli GS, Mavros MN, Spiropoulos T, Barbas SG, Falagas ME. Association between use of air-conditioning or fan and survival of elderly febrile patients: a prospective study. Eur J Public Health 2013;32:1143-7.
  2. Spanos A, Theocharis G, Karageorgopoulos DE, Peppas G, Fouskakis D, Falagas ME. Surveillance of community outbreaks of respiratory tract infections based on house-call visits in the metropolitan area of Athens, Greece. PLoS ONE 2012;7:e40310.
  3.  Maraki S, Mavros MN, Kofteridis DP, Samonis G, Falagas ME. Epidemiology and antimicrobial    susceptibility of 536 multidrug-resistant Gram-negative bacilli isolated from patients treated in surgical wards. Surg Infect 2012;13:326-31.
    1. Samonis S, Karageorgopoulos DE, Maraki S, Levis P, Dimopoulou D, Spernovasilis NA, Kofteridis DP, Falagas ME. PLoS ONE 2012;7:e37375.
    2. Maraki S, Samonis G, Karageorgopoulos DE, Mavros MN, Kofteridis D, Falagas ME. In vitro antimicrobial susceptibility to isepamicin of 6296 Enterobacteriaceae clinical isolates collected at a tertiary-care University Hospital in Greece. Antimicrob Agents Chemother 2012;56:3067-73.
    3. Theocharis G, Polyzos KA, Vouloumanou EK, Peppas G, Spiropoulos T, Barbas SG, Falagas ME. Morbidity of foreign travelers in Attica, Greece: a retrospective study. Eur J clin Microbiol Infect Dis 2012 Feb 2. [Epub ahead of print].
    4. Samonis G, Koutsounaki E, Karageorgopoulos DE, Mitsikostas P, Kalpadaki C, Bozionelou V, Bompolaki I, Sgouros J, Taktikou V, Falagas ME. Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study. Eur J Clin Microbiol Infect Dis 2011 Oct 31. [Epub ahead of print].
    5. Theocharis G, Mavros MN, Vouloumanou EK, Peppas G, Barbas SG, Spiropoulos T, Falagas ME. Comparison of morbidity of elderly patients in August and November in Attica, Greece: a prospective study. Int J Clin Pract 2012;66:84-90.
    6. Bliziotis IA, Petrosillo N, Michalopoulos A, Samonis G, Falagas ME. Impact of definitive therapy with beta-lactam monotherapy or combination with an aminoglycoside or a quinolone for Pseudomonas aeruginosa bacteremia. PLoS One 2011;6:e26470.
    7. Alexiou VG, Michalopoulos A, Makris GC, Peppas G, Samonis G, Falagas ME. Multi-drug-resistant gram-negative bacterial infection in surgical patients hospitalized in the ICU: a cohort study. Eur J Clin Microbiol Infect Dis 2011 Jul 28. [Epub ahead of print].
    8. Hatziagelaki E, Karageorgopoulos DE, Chounta A, Tsiavou A, Falagas ME, Dimitriadis G. Predictors of impaired glucose regulation in patients with non-alcoholic fatty liver disease. Exp Diab Res 2012;2012:351974.
    9. Samonis G, Maraki S, Karageorgopoulos DE, Vouloumanou EK, Falagas ME. Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against MDR Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates. Eur J Clin Microbiol Infect Dis 2011 Jul 31. [Epub ahead of print].
    10. Sun C, Falagas ME, Wang R, Karageorgopoulos DE, Yu X, Liu Y, Cai Y, Liang B, Song X, Liu Z. In vitro activity of minocycline combined with fosfomycin against clinical isolates of methicillin-resistant Staphylococcus aureus. J Antibiotics 2011;64:559-62..
    11. Sideri G, Falagas ME, Grigoriou M, Vouloumanou EK, Papadatos JH, Evangelia L, Kafetzis DA. Liposomal amphotericin B in critically ill pediatric patients. J Clin Pharm Ther 2011 Jul 21 [Epub ahead of print].
    12. Kageorgopoulos DE, Vouloumanou EK, Korbila IP, Kapaskelis A, Falagas ME. Analysis of the age distribution of cases of 2009 (H1N1) pandemic influenza in comparison with seasonal influenza. PLoS ONE 2011;6:e21690.
    13. Koutzavekiaris I, Vouloumanou EK, Gourni M, Rafailidis PI, Michalopoulos A, Falagas ME. Knowledge and practices followed regarding the prevention of infections associated with central venous catheters (CVCs): a survey of intensive care unit medical and nursing staff. Am J Infect Control 2011 Apr 14. [Epub ahead of print].
    14. Sideri G, Kafetzis DA, Vouloumanou EK, Papadatos JH, Papadimitriou M, Falagas ME. Ciprofloxacin in critically ill paediatric patients. Anaesth Intens Care 2011;39:635-9.
    15. Theocharis G, Vouloumanou EK, Barbas SG, Spiropoulos T, Rafailidis PI, Falagas ME. Comparison of characteristics of outpatients with 2009 H1N1 pandemic and seasonal influenza. Int J Clin Pract 2011;65:871-8.
    16. Karageorgopoulos DE, Lamnatou V, Sardi TA, Gkegkes ID, Falagas ME. Temporal trends in the impact factor of European versus USA biomedical journals. PLoS ONE 201;6:e16300.
    17. Samonis S, Maraki S, Rafailidis PI, Kapaskelis A, Kastoris AC, Falagas ME. Antimicrobial susceptibility of Gram-negative non-urinary bacteria to fosfomycin and other antimicrobials. Future Microbiol 2010;5:961-70.
    18. Falagas ME, Kouranos VD, Michalopoulos A, Rodopoulou SP, Batsiou MA, Karageorgopoulos DE. Comparison of the distribution of citations received by articles published in high, moderate, and low impact factor journals in clinical medicine. Intern Med J 2010;40:587-91.
    19. Kondilis BK, Akrivos PD, Sardi TA, Soteriades ES, Falagas ME. Readability Levels of Health Pamphlets distributed in Athens Hospitals & Health Centers. Public Health 2010;124:547-52.
    20. Samonis G, Vouloumanou EK, Christofaki M, Dimopoulou D, Maraki S, Triantafyllou E, Kofteridis DP, Falagas ME. Serratia infections in a general hospital: characteristics and outcomes. Eur J Clin Microbiol Infect Dis 2011 Jan 10. [Epub ahead of print].
    21. Theocharis G, Vouloumanou EK, Rafailidis PI, Spiropoulos T, Barbas SG, Falagas ME. Evaluation of a direct test for seasonal influenza in outpatients. Eur J Intern Med 2010;21:434-8.
    22. Mavros MN, Mitsikostas P, Kontopidis I, Moris D, Dimopoulos G, Falagas ME. H1N1v influenza vaccine in Greek medical students. Eur J Pulic Health 2010 Sep 17. [Epub ahead of print].
    23. Alexiou VG, Ierodiakonou V, Peppas G, Falagas ME. Antimicrobial prophylaxis in surgery: an international survey. Surg Infect (Larchmt). 2010;11:343-8.
    24. Falagas ME, Vouloumanou EK, Plessa E, Peppas G, Rafailidis PI. Inaccuracies in dosing drugs with teaspoons-tablespoons. Int J Clin Pract 2010;64:1185-9.
    25. Plessa E, Diakakis P, Gardelis J, Thirios T, Koletsi P, Falagas ME. Clinical features, risk factors, and complications among pediatric patients with pandemic influenza A (H1N1). Clin Ped 2010;49:777-81.
    26. Falagas ME, Sideri G, Korbila IP, Vouloumanou EK, Papadatos JA, Kafetzis DA. Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis. Ped Pulm 2010 Jul 23. [Epub ahead of print].
    27. Mantadakis E, Tsalkidis A, Panopoulou M, Pagkalis S, Tripsianis G, Falagas ME, Kartali-Ktenidou S, Chatzimichael A. Antimicrobial susceptibility of pediatric uropathogens in Thrace, Greece. Int Urol Nephrol 2010 Jun 4. [Epub ahead of print].
    28. German V, Kopterides P, Poulikakos P, Giannakos G, Falagas ME. Respiratory tract infections in a military recruit setting: a prospective cohort study. J Infect Public Health 2008;1:101-104.
    29. Varbobitis IC, Pappas G, Karageorgopoulos DE, Anagnostopoulos I, Falagas ME. Decreasing trends of ultrasonographic prevalence of cystic echinococcosis in a rural Greek area. Eur J Clin Microbiol Infect Dis 2010;29:307-9.
    30. Falagas ME, Maraki S, Karageorgopoulos DE, Kastoris AC, Kapaskelis A, Samonis G. Antimicrobial susceptibility of Gram-positive non-urinary isolates to fosfomycin. Int J Antimicrob Agents 2010;35:497-9.
    31. Falagas ME, Kouranos VD, Michalopoulos A, Rodopoulou SP, Athanasoulia AP, Karageorgopoulos DE. Inadequate statistical power of published comparative cohort studies on ventilator-associated pneumonia to detect mortality differences between the compared groups. Clin Infect Dis 2010;50:468-72.
    32. Maraki S, Samonis G, Rafailidis PI, Vouloumanou EK, Mavromanolakis E, Falagas ME. Antimicrobial susceptibility of urinary bacteria to fosfomycin. Antimicrob Agents Chemother 2009;53:4508-10.
    33. Falagas ME, Rafailidis PI, Ioannidou E, Alexiou VG, Matthaiou DK, Karageorgopoulos DE, Kapaskelis A, Nikita D, Michalopoulos A. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents 2010;35:194-9.
    34. Falagas ME, Maraki S, Karageorgopoulos DE, Kastoris AC, Mavromanolakis E, Samonis G. Antimicrobial susceptibility of MDR and XDR Enterobacteriaceae isolates to fosfomycin. Int J Antimicrob Agents 2010;35:240-3.
    35. Kakisi O, Grammatikos AA, Karageorgopoulos DE, Athanassoulia AP, Papadopoulou AV, Falagas ME. Prevalence of hepatitis B, hepatitis C, and HIV infections in psychiatric hospitalized patients in Greece. Psychiatr Serv 2009;60:1269-72.
    36. Valkimadi PE, Karageorgopoulos DE, Vliagoftis H, Falagas ME. Increasing dominance of English in publications archived by PubMed. Scientometrics 2009;81:219-223.
    37. Falagas ME, Siempos II, Rafailidis PI, Korbila IP, Ioannidou E, Michalopoulos A. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series. Resp Med 2009;103:707-13.
    38. Falagas ME, Ierodiakonou V, Alexiou VG. Clinical practice of obtaining blood cultures from patients with a central venous catheter (CVC) in place: an international survey. Clin Microbiol Infect 2009;15:683-6.
    39. Falagas ME, Peppas G, Matthaiou DK, Karageorgopoulos DE, Karalis N, Theocharis G. Effect of meteorological variables on the incidence of lower urinary tract infections. Eur J Clin Microbiol Infect Dis 2009;28:709-12.
    40. Vardakas KZ, Michalopoulos A, Kiriakidou KG, Siampli EP, Samonis G, Falagas ME. Candidemia: incidence, risk factors, characteristics, and outcomes in immunocompetent critically ill patients and outcomes in immunocompetent critically ill patients. Clin Microbiol Infect 2009;15:289-92.
    41. Falagas ME, Sideri G, Vouloumanou EK, Papadatos JH, Kafetzis DA. Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis. Pediatr Infect Dis J 2009;28:123-7.
    42. Siempos II, Spanos A, Issaris EA, Rafailidis PI, Falagas MF. Non-physicians may reach correct diagnoses by using Google: a pilot study. Swiss Med Weekly 2008;138:741-5.
    43. Christodoulou C, Pervena A, Klouvas G, Galani E, Falagas ME, Tsakalos G, Visvikis A, Nikolakopoulou A, Acholos V, Karapanagiotidis G, Batziou E, Skarlos DV. Combination of bisphosphonates and anti-angiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone. Oncology 2009;76:209-11.
    44. Konstandinidou K, Mantadakis E, Falagas ME, Sardi T, Samonis G. The role of the Venetian rule in the control of plague epidemics in the Ionian islands during the 17th and 18th century. Emerg Infect Dis 2009;15:39-43.
    45. Vardavas C, Kondilis BK, Patelarou E, Akrivos PD, Falagas ME. Health literacy and sources of health education among adolescents in Greece. Int J Adolesc Med Health 2009;21:179-86.
    46. Falagas ME, Ierodiakonou V, Alexiou VG. At what age do biomedical scientists do their best work? FASEB J 2008;22:4067-70.
    47. Falagas ME, Rafailidis PI, Matthaiou DK, Virtzili S, Nikita D, Michalopoulos A. Pandrug-resistant (PDR) Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients. Int J Antimicrob Agents 2008;32:450-4.
    48. Kapaskelis AM, Vouloumanou EK, Rafailidis PI, Hatzopoulou P, Nikita D, Falagas ME. High prevalence of antibody titers against Bordetella pertussis in an adult population with prolonged cough. Resp Med 2008;102:1586-91.
    49. Samonis G, Karageorgopoulos DE, Kofteridis DP, Matthaiou DK, Sidiropoulou V, Maraki M, Falagas ME. Citrobacter infections in a general hospital: characteristics and outcomes. Eur J Clin Microbiol Infect Dis 2009;28:61-8.
    50. Falagas ME, Kouranos VD, Arencibia-Jorge R, Karageorgopoulos DE. Comparison of SCImago journal rank indicator with journal impact factor. FASEB J 2008;22:2623-8.
    51. Panos G, Samonis G, Alexiou VG, Kavarnou GA, Charatsis G, Falagas ME. Mortality and morbidity of HIV infected patients receiving HAART: a cohort study. Curr HIV Res 2008;6:257-60.
    52. Kondilis BK, Kiriaze IJ, Athanasoulia AP, Falagas ME. Mapping health literacy research in the European Union: a bibliometric analysis. PLoS ONE 2008;3:e2519.
    53. Matthaiou DK, Michalopoulos A, Rafailidis PI, Karageorgopoulos DE, Papaioannou V, Ntani G, Samonis G, Falagas ME. Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: a matched case-control study. Crit Care Med 2008;36:807-11.
    54. Iavazzo C, Vogiatzi C, Falagas ME. A retrospective analysis of isolates from patients with vaginitis in a Greek private obstetrical/gynecological hospital (2003-2006). Med Sci Monit 2008;14:CR228-231.
    55. Papassotiriou I., Alexiou VG, Tsironi M, Skenderi, Spanos A, Falagas ME. Severe aseptic inflammation caused by long distance running (246 km) does not increase procalcitonin. Eur J Clin Invest 2008;38:276-9.
    56. Falagas ME, Mourtzoukou EG, Giannopoulou KP, Alexiou VG, Rafailidis PI. Matching criteria in case-control studies in the field of antimicrobial resistance. Microb Drug Resist 2008;14:171-82.
    57. Falagas ME, Mourtzoukou EG, Ntziora F, Peppas G, Rafailidis PI. Matching criteria in case-control studies on postoperative infections. J Hosp Infect 2008;69:101-13.
    58. Samonis G, Kofteridis DP, Saloustros E, Giannopoulou KP, Ntziora F, Christidou A, Maraki S, Falagas ME. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data. Scand J Infect Dis 2008;40:414-9.
    59. Athanasiou S, Pitsouni E, Iavazzo C, Karamanis EM, Falagas ME. World Wide Web resources on obstetrical and gynecological infections. Infect Dis Obstet Gyn 2007;2007:29232.
    60. Falagas ME, Charitidou E, Alexiou VG. ‘Article’ and journal impact factor in various scientific fields. Am J Med Sci 2008;335:188-91.
    61. Falagas ME, Pitsouni EI, Bliziotis IA. Trends in the methodological quality of published randomized controlled trials on antibacterial agents. Br J Clin Pharmacol 2008;65:942-54.
    62. Alexiou VG, Falagas ME. e-meducation.org: an open access medical education web portal. BMC Med Educ 2008;8:6.
    63. Falagas ME, Theocharis G, Spanos A, Vlara LA, Issaris EA, Panos G, Peppas G. Effect of meteorological variables on the incidence of respiratory tract infections. Resp Med 2008;102:733-7.
    64. Falagas ME, Kanellopoulou MD, Karageorgopoulos DE, Dimopoulos G, Rafailidis PI, Skarmoutsou ND, Papafrangas EA. Antimicrobial susceptibility of multidrug resistant Gram-negative bacteria to fosfomycin. Eur J Clin Microb Infect Dis 2008;27:439-43.
    65. Falagas ME, Polemis M, Alexiou VG, Mastrogiannaki A, Kremastinou J, Vatopoulos AC. Antimicrobial resistance of Escherichia coli urinary isolates from primary care patients in Greece. Med Sci Monit 2008;14:CR75-79.
    66. Dimopoulos G, Ntziora F, Rachiotis R, Armaganidis A, Falagas ME. Candida albicans versus non-albicans ICU acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg 2008;106:523-9.
    67. Falagas ME, Alexiou VG. An analysis of trends in globalization of origin of research published in major general medical journals. Int J Clin Pract 2008;62:71-5.
    68. Panos G, Charatsis G, Paparizos V, Kazantzi M, Falagas ME. Prevalence of genotypic resistance to nucleoside analogues, non-nucleoside analogues and protease inhibitors in HIV-infected persons in Athens, Greece. AIDS Res Human Retrov 2008;24:43-51.
    69. Rafailidis PI, Falagas ME. Discordance between data acquired by history and findings of physical examination: a phenomenal paradox. Eur J Intern Med 2008;19:271-5.
    70. Michalopoulos A, Fotakis D, Virtzili S, Vletsas C, Raftopoulou S, Mastora Z, Falagas ME. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria in critically ill patients. Resp Med 2008;102:407-12.
    71. Mastoraki E, Michalopoulos A, Kriaras I, Mouchtouri E, Falagas ME, Karatza D, Geroulanos S. Incidence of postoperative infections in patients undergoing open-heart surgery receiving antimicrobial prophylaxis with original and generic cefuroxime. J Infect 2008;56:35-9.
    72. Falagas ME, Rafailidis PI, Kofterides D, Virtzili S, Helvatzoglou F, Papaioannou V, Maraki S, Samonis G, Michalopoulos A. Risk factors of carbapenem resistant Klebsiella pneumoniae infections: a matched case-control study. J Antimicrob Chemother 2007;60:1124-30.
    73. Rosmarakis ER, Prapas SN, Rellos K, Michalopoulos A, Samonis G, FalagasME. Nosocomial infections after off-pump coronary artery bypass surgery: frequency, characteristics, and risk factors. Interact Cardiovasc Thorac Surg 2007;6:759-67.
    74. Fragoulis KN, Korbila IP, Dimopoulos G, Falagas ME. Open access World Wide Web resources on upper and lower respiratory tract infections. Int J Tuberc Lung Dis 2007;11:1237-45.
    75. Kopterides P, Koletsi PK, Michalopoulos M, Falagas ME. Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates. Int J Antimicrob Agents  2007;30:409-14.
    76. Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of Pub Med, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J 2008;22:338-42.
    77. Athanasiou S, Antsaklis A, Betsi GI, Sotiropoulou M, Falagas ME. Clinical and urodynamic parameters associated with history of urinary tract infections in women. Acta Obstet Gynecol Scand 2007;86:1130-5.
    78. Falagas ME, Karveli EA, Tritsaroli VI. The risk of using the Internet as reference resource: a comparative study. Int J Med Informatics 2008;77:280-6.
    79. Dimopoulos G, Karabinis A, Samonis G, Falagas ME. Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study. Eur J Clin Microbiol Infect Dis 2007;26:377-84..
    80. Fragoulis KN, Vardakas KZ, Falagas ME. Open access World Wide Web resources on urogenital infections. Nephr Dialysis Tranplant 2007;22:3046-7.
    81. Falagas ME, Karveli EA, Panos G. World Wide Web resources of open access, educational infectious diseases clinical cases. Clin Infect Dis 2007;45:495-500.
    82. Falagas ME, Mourtzoukou E, Polemis M, The Greek System for Surveillance of Antimicrobial Resistance, Vatopoulos AC. Trends in antimicrobial resistance of Acinetobacter baumannii clinical isolates from hospitalized patients in Greece and treatment implications. Clin Microbiol Infect 2007;13:816-9.
    83. Christopoulos P, Falagas ME, Gourzis P, Trompoukis C. Aspects of informed consent in medical practice in the Eastern Mediterranean region during the 17-18th century. World J Surg 2007;31:1587-91.
    84. Panos GZ, Xirouchakis E, Tzias V, Charatsis G, Bliziotis IA, Doulgeroglou V, Margetis N, Falagas ME. Helicobacter pylori infection in symptomatic HIV seropositive and seronegative patients: a case-control study. AIDS Res Human Retrov 2007;23:709-12.
    85. Falagas ME, Rafailidis PI. When to include polymyxins in the empirical antibiotic regimen in critically ill patients with fever? A decision analysis approach. Shock 2007;27:605-609.
    86. Falagas ME, Bliziotis IA,Michalopoulos A, Sermaides G, Papaioannou VE, Nikita D, Choulis N. Effect of a policy for restriction of selected classes of antibiotics on antimicrobial drug cost and resistance. J Chemother 2007;19:178-84.
    87. Soteriades ES, Falagas ME. A bibliometric analysis in the fields of preventive medicine, occupational and environmental medicine, epidemiology, and public health. BMC Public Health 2006;6:301.
    88. Falagas ME, Karydis I, Kostogiannou I. Percutaneous exposure incidents of the health care personnel in a newly founded tertiary hospital: a prospective study. PLoS ONE 2007;2:e194.
    89. Pappas G, Falagas ME. Free Internal Medicine case-based education through the World Wide Web: how, where, with what. Mayo Clin Proc 2007;82:203-7.
    90. Falagas ME, Bliziotis IA, Kondilis B, Soteriades ES. Eighteen years of research on AIDS: Contribution of and collaborations between different world regions. AIDS Res Hum Retroviruses 2006;22:1199-205.
    91. Kondilis B, Soteriades ES, Falagas ME. Readability levels of health pamphlets distributed during the Athens 2004 Olympic Games. Public Health 2007;121:189-92.
    92. Falagas ME, Fragoulis KN, Karydis I. A comparative study on the cost of new antibiotics and drugs of other therapeutic categories. PLoS ONE 2006;1:e11.
    93. Pappas G, PapadimitriouP, Falagas ME.World Wide Web hepatitis B virus resources. J Clin Virol 2007;38:161-4.
    94. FalagasME, KavvadiaPK, MantadakisE, Kofteridis DP, Bliziotis IA, SaloustrosE, MarakiS, SamonisMorganella morganii infections in a general tertiary hospital. Infection 2006;34:315-21
    95. GermanG, Giannakos G, KopteridesP, LiaskonisK, Falagas ME. Serologic indices of hepatitis B virus infection in military recruits in Greece (2004-2005). BMC Infect Dis 2006;6;163.
    96. Pappas G, Siozopoulou V, Akritidis N, Falagas ME. Physicians’ attitudes towards aspects of brucellosis treatment: convenience reigns over science. J Infect2007;54:459-62.
    97. Peppas G, Theocharis G, Karveli EA, Falagas ME. An analysis of patient house calls in the area of Attica, Greece. BMC Health Serv Res 2006;6:112.
    98. Falagas ME, Michalopoulos AS, Bliziotis IA, Soteriades ES. A bibliometric analysis by geographic area of published research in several biomedical fields (1995-2003). CMAJ 2006;175:1389-90.
    99. Falagas ME, RafailidisPI, KasiakouSK, Hatzopoulou P, Michalopoulos A. Effectiveness and nephrotoxicity of colistin monotherapy versus colistin/meropenem combination therapy for multidrug-resistant Gram negative bacterial infections. Clin Microbiol Infect 2006;12:1227-30.
    100. Falagas ME, Rosmarakis ES, Avramopoulos I, Vakalis N. Streptococcus agalactiae infections in non-pregnant adults: single center experience of a growing clinical problem. Med Sci Monit 2006;12:CR447-451.
back to top

Scientific Director

Matthew E. Falagas
MD, MSc, DSc

- Director, Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece
- Director, 1st Department of Internal Medicine, HYGEIA Hospital
- Adjunct Associate Professor of Medicine, Tufts University School of Medicine, Boston, Massachusetts

View CV

Services

Travel Medicine
Travel Medicine
People who travel may be exposed to dangers, which might have an impact on their entertainment or business plans (traveler's diarrhea, jet lag, malaria, yellow…
Inpatient Care
Inpatient Care
We admit our patients to HYGEIA Hospital, a pioneering, private institute, which everyone can trust his/her health. If admission of a patient is required for…
Outpatient Care
Outpatient Care
24 hours/day, 365 days/year availability of scientific staff to help patients.Telephone (210-68.39.600 and 6946-100.000 for emergencies) for easy access to services. 1. Attendance in our…

Academic Activities

Congress Organisation

One of the goals of Alfa HealthCare is to contribute to the organization of high-quality bio-medical conferences in Greece and abroad

Research

In colaboration with AIBE we have many important research programs in the fields of pathology

Εducation

We invest in the education of our medical, scientific, and nursing staff as well as in new medicine methods.

About

Alfa HealthCare S.A. is a medical anonymous company founded in 2002 in Athens, Greece. Our first goal is to provide high quality medical care, in the fields of Internal Medicine and Infectious Diseases. We offer outpatient care, as well as, secondary and tertiary care at the hospital level. ...

Read more

Google Map

Alfa HealthCare Α.Ε.

 

Medical Services
Internal Medicine - Infectious Diseases
9 Neapoleos Str., 151 23 Marousi,
Athens, Greece

Tel.: +30-210-68.39.600
Emergencies: +30-694-61.10.000

Email: info@alfahc.gr

© Copyright 2014 - Design & Development by In-Com. All rights Reserved